
Helus Pharma
HELPAEQUITAS NEO EXCHANGEKey Statistics
Open
$4.49
Day High
$4.58
Day Low
$4.40
Prev. Close
$4.49
VolumeShares traded today.
369.93K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$227.66M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-1.26
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$9.83
52W LowLowest price over the past 52 weeks.
$4.15
50D MAAverage closing price over the last 50 trading days.
$5.01
200D MAAverage closing price over the last 200 trading days.
$6.19
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-1.1%1M
-7.3%6M
-26.3%YTD
-45.0%1Y
-43.8%About
Helus Pharma, also known formerly as Cybin IRL, is a Canadian pharmaceutical company that was led by CEO Doug Drysdale from 2020-2025, developing psychedelic drugs as medicines.
www.helus.comCompany Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade HELP
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.